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Key Messages
1. This smoking reduction study examined 
the effectiveness of smoking reduction 
counselling together with free nicotine 
replacement therapy (NRT) for smoking 
cessation and tested the effectiveness of 
brief counselling on adherence to NRT 
among Chinese smokers who were not 
willing to quit but intended to reduce 
cigarette consumption.
2. The smoking reduction intervention 
was effective in helping the 
unmotivated smokers in quitting 
(intervention: 17.0% vs control: 10.2%, 
P=0.012) and in reducing their daily 
cigarette consumption by 50% or more 
(intervention: 50.9% vs control: 25.7%, 
P<0.001) at 6-month follow-up.
3. Our results provided evidence for the 
effectiveness of smoking reduction 
intervention, which is important for 
planning smoking cessation services.
4. Free NRT was widely accepted by 
participants (8-week NRT adherence 
rate: 54.5%). Free NRT together with 
smoking reduction counselling was a 
feasible and cost-effective approach to 
help unmotivated smokers to reduce and 
quit smoking, especially in developing 
countries like China where NRT is 
expensive and not used extensively.
5. The motivation to quit smoking was 
not undermined by smoking reduction 
intervention. To the contrary, offering 
assistance to reduce smoking could 
attract smokers who were not willing or 
ready to quit.
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Introduction
China has the largest smoking population in the world, but most smokers are not 
willing to quit smoking. In Hong Kong, the prevalence of smoking was 11.8% in 
2008, according to a household survey.1 Although smoking cessation decreases 
the health risks associated with tobacco use, many smokers were unmotivated 
to quit, and 67% of Hong Kong Chinese smokers had never tried to give up 
smoking.1 Smoking reduction may provide an intermediate step for complete 
cessation, especially for those who are unready or unwilling to quit. Although 
nicotine replacement therapy (NRT) increases the quit rate, few smokers 
undergoing NRT adhere to the recommended regimen.2 
 There has been no randomised controlled trial on intervention to increase 
NRT adherence. The present study aimed to evaluate the effectiveness of 
smoking reduction therapy and adherence intervention for 6 months among 
Chinese smokers in Hong Kong who were unmotivated to quit smoking. We 
hypothesised that the smoking reduction and adherence counselling would lead 
to a higher rate of abstinence, reduction, and adherence to NRT, compared to 
controls.
Methods
A single-blinded randomised controlled trial was conducted from October 
2004 to April 2007. Subjects were eligible for inclusion if they were ethnic 
Chinese, aged 18 years or above, smoked at least two cigarettes daily, had no 
intention to quit in the near future or had failed in previous attempts to quit 
using NRT, intended to reduce smoking within the next 7 days using NRT, had 
no contraindication to NRT, and were not following other smoking cessation 
or reduction interventions. People who were psychologically or physically 
unable to communicate, pregnant or intending to become pregnant within the 
next 6 months, on regular psychotropic medications, or with any serious health 
problems such as stroke, palpitations or other life-threatening conditions were 
excluded. 
 After informed consent, the subjects were randomised into the control group 
or one of the two intervention groups. In the control group, subjects received 
simple advice on smoking cessation and a self-help quitting pamphlet only. In 
the reduction and adherence intervention group, subjects received 15-minute 
face-to-face smoking reduction counselling and 3-minute adherence counselling 
for NRT by a trained smoking cessation counsellor. Information on health 
consequences of smoking and benefits of quitting was provided. Smokers were 
encouraged to reduce consumption before quitting. Using the ‘5R’ approach 
(relevance, risk, rewards, roadblocks, and repetition), the counselling focused 
on the importance and function of smoking reduction when complete cessation 
is difficult. In addition, the importance of adherence to the prescribed NRT 
dosage and the advantages of adherence were emphasised. Ways to overcome 
barriers were discussed. Problem-orientated interventions to improve adherence 
were delivered. Strict adherence to the prescribed dosage for at least 4 weeks 
was advised. In the reduction intervention group, subjects received smoking 
reduction counselling only. 
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 For both intervention groups, 1 week of NRT was 
provided at the first contact. Further smoking reduction 
counselling and free NRT were provided at the 1-week 
and 4-week follow-ups. For the reduction and adherence 
intervention group, NRT usage was checked by counting the 
amount of NRT left, and additional adherence counselling 
was provided. At month 3, information on NRT use in the 
intervention groups up to 4 and 8 weeks was collected. At 
month 6, all subjects (including controls) were interviewed 
via telephone using a standard questionnaire. All self-
reported quitters (with 7-day abstinence) and reducers 
(reducing daily consumption by ≥50%) were invited for 
biochemical validation of exhaled carbon monoxide and 
urinary cotinine levels. 
 The primary outcome measures were: (1) self-reported 
7-day point-prevalence tobacco abstinence at month 
6, (2) self-reported reduction rate (≥50%) of cigarette 
consumption at month 6 between the intervention and 
control groups, and (3) rate of continuous NRT use for 4 
weeks (4-week adherence rate) at month 3 between the two 
intervention groups. Secondary outcome measures were: 
(1) validated quit rate at month 6, (2) self-reported quit rate 
at month 1, (3) self-reported continuous use of NRT for at 
least 8 weeks, and (4) the number of quit attempts up to 
month 6.
 The required sample size was calculated based on 
primary outcome measures to provide at least 90% power 
with a significance level of 5%. We estimated that there 
would be (1) a 4% difference in the self-reported quit rate 
between the intervention and control groups, (2) a 12% 
difference in the self-reported reduction rate between the 
intervention and control groups, and (3) a 10% difference 
in the adherence rate between the intervention groups. 
Thus, 3246 subjects (1229 in the reduction and adherence 
intervention group, 1229 in the reduction intervention 
group, and 788 in the control group) were needed. 
Fig. Consolidated standards of reporting trials flow chart of the study
Assessed for eligibility (n=14 953)
Consented and completed baseline questionnaire (n=1154)
Excluded (n=13 809)
Not meeting inclusion criteria (n=8578)
Refused to participate (n=5231)
Reduction and adherence group 
(n=479) received smoking reduction 
counselling with adherence intervention 
and 1 week’s free nicotine replacement 
therapy (NRT) 
At week 1, subjects received further 
face-to-face (n=404) or telephone 
(n=16) smoking reduction counselling 
with adherence intervention and 3 
week’s free NRT 
At month 1, subjects received further 
face-to-face (n=347) or telephone 
(n=34) smoking reduction counselling 
with adherence intervention and 4 
week’s free NRT
At month 1, subjects received further 
face-to-face (n=331) or telephone 
(n=22) smoking reduction counselling 
and 4 week’s free NRT 
At week 1, subjects received further 
face-to-face (n=376) or telephone 
(n=13) smoking reduction counselling 
and 3 week’s free NRT
Reduction intervention group (n=449) 
received smoking reduction counselling 
and 1 week’s free NRT 
Control group (n=226) received simple 
advice and self-help quitting pamphlet
Lost to follow-up (n=59)
Refused (n=52)
Lost contact (n=7)
Lost to follow-up (n=98)
Refused (n=15)
Lost contact (n=83)
Rejoined (n=59)
Lost to follow-up (n=31)
  Refused (n=31)
Rejoined (n=77)
Lost to follow-up (n=23)
  Refused (n=23)
Rejoined (n=75)
Lost to follow-up (n=96)
Refused (n=16)
Lost contact (n=80)
Rejoined (n=60)
Lost to follow-up (n=60)
Refused (n=54)
Lost contact (n=6)
Lost to follow-up (n=10)
Refused (n=5)
Lost contact (n=5)
6-month follow-up (n=427) 6-month follow-up (n=405) 6-month follow-up (n=216)
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 All analyses were based on the intention-to-treat 
principle. To test the effectiveness of the smoking reduction 
counselling and NRT, the two intervention groups were 
combined and compared with the control group. To test 
the effectiveness of the adherence intervention to NRT, 
the two intervention groups were compared. Recruitment 
of subjects was stopped upon advice from the Independent 
Data Monitoring Committee after the interim analysis 
showed that the self-reported quit rate at month 6 was 
significantly different between the intervention and control 
groups, and that the adherence rates to NRT between the 
two intervention groups were almost identical. Tobacco 
abstinence rates, reduction rates, and the adherence rates 
between groups were compared using the Pearson Chi-
squared test, odds ratios, and 95% confidence intervals.
Results
From October 2004 to April 2007, 1154 participants were 
randomised into the smoking reduction and NRT adherence 
intervention group (n=479), the smoking reduction group 
(n=449), and the control group (n=226). A consolidated 
standards of reporting trials flow chart detailing the 
enrolment, allocation and follow-up of participants is 
shown in the Figure. Table 1 outlines characteristics of 
participants and results of baseline measurements. No 
significant difference was noted in baseline variables across 
the three groups, except that there were more females in 
the reduction and adherence intervention group (22.1% 
vs 16.5% vs 12.4% respectively, Table 1). The follow-up 
rates of the combined intervention group at the 1-week, 
1-month, and 3-month follow-up were 87.2%, 79.1%, and 
85.9%, respectively. At 6 months, 89.7% of the combined 
intervention group and 95.6% of the control group were 
followed up. 
Cigarette consumption and abstinence
Smoking status of all subjects was assessed by research 
assistants at the 6-month follow-up by telephone interview. 
The mean daily cigarette consumption of the intervention 
groups was significantly lower than that of the controls 
(9.5 vs 13.1 cigarettes, P<0.001, Table 2). The quit 
rate was significantly higher in the intervention groups 
than the controls (17.0% vs 10.2%, P=0.012, Table 2). 
Subjects who reported complete abstinence were invited 
for biochemical validation, and the participation rate was 
56.4% (102/181); 74 (quit rate of 8.0%) of the intervention 
group subjects passed the validation test, with urinary 
cotinine concentrations of <115 ng/ml and expired carbon 
monoxide levels of <9 ppm, compared to 10 (quit rate of 
4.4%) of the controls (P=0.066).
Smoking reduction and quit attempts
Successful smoking reduction was defined as a self-reported 
reduction in daily cigarettes by ≥50% at the 6-month 
follow-up. The smoking reduction rates were significantly 
Table 1. Patients’ demographics, smoking profiles, quitting history, and self-efficacy to resist smoking at baseline*
Parameter Reduction and adherence 
intervention (n=479)
Reduction intervention 
(n=449)
Control (n=226)
Male 373 (77.9) 375 (83.5) 198 (87.6)
Female 106 (22.1) 74 (16.5) 28 (12.4)
Patient age (years) 41.5±10.3 42.4±10.3 42.5±11.2
Marital status
Married/cohabiting 323 (67.4) 335 (74.8) 153 (67.7)
Others 156 (32.6) 113 (25.2) 73 (32.3)
Education level
Primary or below 53 (11.1) 48 (10.7) 27 (11.9)
Secondary 331 (69.1) 329 (73.4) 156 (69.1)
Tertiary or above 95 (19.8) 71 (15.8) 43 (19.0)
Smoking profiles
Age started smoking (years) 18.0±4.6 17.5±4.8 17.8±4.8
Years of regular smoking 23.5±10.8 24.8±9.9 24.5±11.1
Daily cigarette consumption 19.8±9.4 20.1±10.1 19.2±8.9
Fagerstrom test
Mild 102 (21.3) 109 (24.3) 56 (24.8)
Moderate 151 (31.5) 134 (29.9) 76 (33.6)
Severe 226 (47.2) 205 (45.8) 94 (41.6)
Quit attempt
0 104 (21.8) 100 (22.4) 43 (19.1)
1 144 (30.1) 122 (27.4) 55 (24.4)
2-5 178 (37.2) 192 (43.0) 109 (48.4)
6-10 21 (4.4) 11 (2.5) 8 (3.6)
>10 31 (6.5) 21 (4.7) 10 (4.4)
Previous use of nicotine replacement therapy 193 (40.3) 166 (37.1) 84 (37.2)
Self-efficacy to resist smoking†
Importance of reducing smoking 82.8±17.3 82.5±17.2 79.7±18.8
Difficulty in reducing smoking 69.0±22.7 69.8±21.7 68.1±22.1
Confidence in reducing smoking 64.9±20.1 63.3±20.5 61.6±20.2
Confidence in quitting smoking (years) 76.3±21.0 75.0±21.7 76.4±20.3
* Data are presented as No. (%) or mean±SD
† Range from 0 indicating not important, not difficult, or not confident at all to 100 indicating very important, very difficult, or very confident
Smoking reduction intervention for smokers not willing to quit smoking
Hong Kong Med J Vol 18 No 4 Supplement 3 August 2012      7
higher in the intervention groups than in the control group, 
including and excluding the quitters (50.9% vs 25.7%, 
P<0.001; 41.2% vs 17.2%, P<0.001, respectively). Those 
who had an expired carbon monoxide level reduced by ≥1 
ppm were classified as validated reducers. The participation 
rate was 48.9% (171/350). There were more validated 
reducers in the intervention groups than the control group 
(11.2% [104/928] vs 5.3% [12/226], P=0.008). Excluding 
the quitters, more smokers in the intervention groups tried 
to stop smoking for at least 24 hours within the previous 30 
days than controls did (22.9% vs 20.7%, P>0.05).
Adherence to nicotine replacement therapy
Comparing the two intervention groups, there was no 
significant difference in the adherence rates to NRT at week 
4 (69.7% vs 67.7%, P=0.51) and week 8 (56.4% vs 52.6%, 
P=0.25), as well as the self-reported 7-day quit rate (14.0% 
vs 12.9%, P=0.91) at month 3. Nonetheless, the quit rate 
was significantly higher in the reduction and adherence 
intervention group (20.9% vs 12.9%, P=0.001).
Discussion
Smoking reduction counselling, with or without NRT 
adherence counselling, was effective in helping ‘pre-
contemplators’ to quit or reduce their daily cigarette 
consumption by ≥50%. This is important for planning 
local smoking cessation services (when most smokers are 
unmotivated to quit) and making smoking reduction an 
intermediate step toward complete cessation. 
 In our study, the effectiveness of the 3-minute adherence 
counselling on NRT was examined. Although there was no 
significant difference in the 4-week and 8-week adherence 
rates between the two intervention groups at the 3-month 
follow up, NRT was widely accepted (54.5%), compared 
to previous studies that have reported rates of 16 to 46%.2-4 
This was likely to be due to provision of free NRT. Cost is 
the main reason for NRT discontinuation; offering free NRT 
with smoking reduction counselling is feasible and cost-
effective in helping unmotivated smokers to reduce and quit 
smoking, especially for those in developing countries like 
China where NRT is expensive and not widely used. 
 Reduction counselling may undermine smoking 
cessation and smokers’ motivation to quit, as smokers 
may rationalise that reducing consumption is what they 
can accomplish and perceive reduction as an alternative to 
complete cessation.5 Our study does not support this notion. 
Compared with the controls at month 6, smoking reduction 
intervention plus nicotine treatment achieved significantly 
higher abstinence rates, reduction rates, and quit attempts. 
No evidence of undermined motivation for quitting 
smoking was noted. To the contrary, offering assistance to 
reduce smoking may attract the smokers who are unwilling 
or unready to quit.
 The main limitation of our study was the difficulty 
in subject recruitment despite vigorous promotional 
campaigns, and thus stopping recruitment before reaching 
our planned number of participants. From our previous 
experience, 60% of the current smokers were not intending 
to quit or join a cessation programme. This percentage 
was much lower when the smokers were sought from our 
database. Further studies on new adherence intervention 
are needed. Our study provided multi-session counselling 
(baseline, 1-week and 1-month) with telephone follow-
up, but 20% of the participants were lost to follow-up and 
hence did not receive the complete intervention, possibly 
weakening effectiveness.
* Quitting is confirmed by an expired carbon monoxide level of <9 ppm and a urinary cotinine level of <115 ng/ml
Table 2. Abstinence, reduction, quit attempts and adherence rates of the intervention and control groups
Abstinence and reduction rate No. (%) of subjects P value Odds ratio
(95% CI)Combined
intervention
(n=928)
Control (n=226)
Self-reported 7-day point prevalence quit rate 158 (17.0) 23 (10.2) 0.012 1.81 (1.14-2.88)
Biochemical validated quit rate* 74 (8.0) 10 (4.4) 0.066 1.87 (0.95-3.70)
Self-reported reduction in daily cigarette consumption by ≥50% 472 (50.9) 58 (25.7) <0.001 3.0 (2.16-4.15)
Tried to quit smoking for at least 24 hours within last 30 days 
(excluding the quitters)
172 (22.9) of 770 42 (20.7) of 203 0.05 0.88 (0.6-1.3)
Reduction and 
adherence 
intervention 
(n=479)
Reduction 
intervention 
(n=449)
Self-reported 7-day point prevalence quit rate at month 3 67 (14.0) 58 (12.9) 0.91 1.1 (0.75-1.60)
Self-reported 7-day point prevalence quit rate at month 6 100 (20.9) 58 (12.9) 0.001 1.78 (1.25-2.53)
Biochemical validated quit rate* 48 (10.0) 26 (5.8) 0.02 1.81 (1.10-2.98)
4-week adherence rate to nicotine replacement therapy at month 3 334 (69.7) 304 (67.7) 0.51 1.1 (0.83-1.45)
8-week adherence rate to nicotine replacement therapy at month 3 270 (56.4) 236 (52.6) 0.25 1.2 (0.90-1.51)
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Conclusion
Smoking reduction counselling together with NRT was 
effective in achieving smoking reduction and complete 
cessation for smokers who were not ready to quit. Although 
there was no significant difference in the 4-week and 8-week 
adherence rates to NRT between the two intervention 
groups, the group receiving the adherence intervention 
achieved a significantly higher quit rate. 
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